Antimicrobials Working Group Revenue and Competitors
Estimated Revenue & Valuation
- Antimicrobials Working Group's estimated annual revenue is currently $1.1M per year.
- Antimicrobials Working Group's estimated revenue per employee is $155,000
Employee Data
- Antimicrobials Working Group has 7 Employees.
- Antimicrobials Working Group grew their employee count by 0% last year.
Antimicrobials Working Group's People
Name | Title | Email/Phone |
---|
Antimicrobials Working Group Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 35 | 0% | N/A | N/A |
#2 | $1.2M | 16 | -6% | N/A | N/A |
#3 | $13.6M | 88 | 4% | N/A | N/A |
#4 | $1.1M | 7 | 40% | N/A | N/A |
#5 | $0.9M | 11 | 10% | N/A | N/A |
#6 | $5.1M | 33 | 3% | N/A | N/A |
#7 | $132.5M | 855 | 6% | N/A | N/A |
#8 | $0.9M | 6 | 0% | N/A | N/A |
#9 | $0.6M | 4 | -20% | N/A | N/A |
#10 | $2.5M | 16 | 7% | N/A | N/A |
What Is Antimicrobials Working Group?
The Antimicrobials Working Group (AWG) was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging antimicrobials and diagnostics companies. Today, The Antimicrobials Working Group is comprised of twelve emerging antimicrobial companies. In seven years of work, we have narrowed our focus onto enhanced reimbursement, expedited approval pathways, and sound stewardship measures. The emergence of multi-drug resistant bacteria presents a global public health crisis that demands new antimicrobials and diagnostic devices, yet the number of companies in the United States investing in research and development is dwindling due to lack of attractiveness for investment in the sector. AWG engages with key Congressional offices to help create policies and legislation that spur the development of life-saving antimicrobials and diagnostic devices through appropriate regulatory flexibility; fair and adequate reimbursement policies; and establishing a favorable investment climate to develop antimicrobial therapies and diagnostic devices.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 7 | N/A | N/A |
#2 | $0.7M | 7 | -22% | N/A |
#3 | $0.5M | 7 | 0% | N/A |
#4 | $0.9M | 7 | 17% | N/A |
#5 | $0.5M | 7 | -12% | N/A |